Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The restructuring of the crop agriculture industry over the past two decades has enabled patent holders to exclude, prevent and deter others from using certain research tools and delay or block further follow-on inventions.
The first approved combination therapy against cystic fibrosis will open up an increasing proportion of patients for treatment. As Anna Azvolinsky reports, companies are banking on it.
Human induced pluripotent stem cells show no consistent differences from human embryonic stem cells in a study that controls for several sources of variability.